Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Chung, Woonbok ^a   Kwabi Addo, Bernard ^a   Ittmann, Michael ^a   Jelinek, Jaroslav ^a   Shen, Lanlan ^a   Yu, Yinhua ^a   Issa, Jean Pierre J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR 5; PROTEIN CLSTN1; PROTEIN DPYS; PROTEIN GALR2; PROTEIN NSE1; PROTEIN SLC16A12; PROTEIN SPOCK2; PROTEIN TOX; TRANSCRIPTION FACTOR NKX2.5; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; DISEASE ACTIVITY; DISEASE MARKER; DNA METHYLATION; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; LEUKEMIA; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; BREAST TUMOR; CELL CLONE; COLON TUMOR; DNA SEQUENCE; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; NEOPLASM; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR GENE;

BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CELL LINE, TUMOR; CLONE CELLS; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; HUMANS; MALE; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 44349087494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002079     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, et al. (2005) Cancer statistics, 2005, Ca-A Cancer Journal for Clinicians 55: 10-30.
2. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypemethylation. N Engl J Med 349: 2042-2054.
3. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JPJ (1998) Alterations in DNA methylation - A fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196.
4. Kang GH, Lee S, Lee HJ, Hwang KS (2004) Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. Journal of Pathology 202: 233-240.
5. Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, et al. (2003) Altered methylation of multiple genes in carcinogenesis of the prostate. International Journal of Cancer 106: 382-387.
6. Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, et al. (2001) The role of epigenetic modifications in retinoic acid receptor beta 2 gene expression in human prostate cancers. Laboratory Investigation 81: 1049-1057.
7. Singal R, van Wert J, Bashambu M (2001) Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Research 61: 4820-4826.
8. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, et al. (1995) E-Cadherin Expression Is Silenced by Dna Hypermethylation in Human Breast and Prostate Carcinomas. Cancer Research 55: 5195-5199.
9. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, et al. (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Research 64: 1975-1986.
10. Liu LM, Yoon JH, Dammann R, Pfeifer GP (2002) Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene 21: 6835-6840.
11. Toyota M, Ho C, Ahuja N, Jair K-W, Ohe-Toyota M, et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
12. Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997.
13. Cottrell SE, Laird PW (2003) Sensitive detection of DNA methylation. Ann N Y Acad Sci 983: 120-130.
14. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R (2003) Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35: 146-150.
15. Xiong ZG, Laird PW (1997) COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Research 25: 2532-2534.
16. Webber MM, Bello D, Kleinman HK, Wartinger DD, Williams DE, et al. (1996) Prostate specific antigen and androgen receptor induction and characterization of ari immortalized adult human prostatic epithelial cell line. Carcinogenesis 17: 1611-1646.
17. Estecio MR, Yan PS, Ibrahim AE, Tellez CS, Shen L, et al. (2007) High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res 17: 1529-1536.
18. Barski A, Cuddapah S, Cui K, Rob TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
19. Smiraglia DJ, Rush LJ, Fruhwald MC, Dai ZY, Held WA, et al. (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Human Molecular Genetics 10: 1413-1419.
20. Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA (1987) Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 47: 6066-6073.
21. Schuebel KE, Chen W, Cope L, Glockner SC, Suzuki H, et al. (2007) Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723.
22. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
23. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, et al. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540.
24. Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, et al. (2007) Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13: 3796-3802.
25. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, et al. (2005) MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97: 1330-1338.
26. Zeng YX, Somasundaram K, ElDeiry WS (1997) AP2 inhibits cancer cell growth and activates p21(WAF1)/(CIP1) expression. Nature Genetics 15: 78-82.
27. Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M (1998) Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. Embo Journal 17: 4358-4369.
28. Schmutte C, Jones PA (1998) Involvement of DNA methylation in human carcinogenesis. Biological Chemistry 379: 377-388.
29. Wimmer K, Zhu XX, Rouillard JM, Ambros PF, Lamb BJ, et al. (2002) Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosomes & Cancer 33: 285-294.
30. Suh ER, Ha CS, Rankin EB, Toyota M, Traber PG (2uO2) DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines. J Biol Chem 277: 35795-35800.
31. Yamada Y, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, et al. (2003) Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. Cancer Science 94: 536-539.
32. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107.